3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Neoplasms
2
Lymphoma, Non-Hodgkin
2
Carcinoma, Renal Cell
2
Zollinger-Ellison Syndrome
1
Uterine Cervical Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Philadelphia Chromosome
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, Follicular
1
Lymphoma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Gastrointestinal Cancer Metastatic
1
Epstein-Barr Virus Infections
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Adenoma, Islet Cell
1
Interventions
Cyclophosphamide
192
Methotrexate
106
Cytarabine
86
fludarabine phosphate
80
Busulfan
71
Tacrolimus
70
Peripheral Blood Stem Cell Transplantation
69
Mycophenolic Acid
69
Whole-Body Irradiation
68
Vincristine
67
fludarabine
61
Filgrastim
61
Etoposide
59
Dexamethasone
54
Melphalan
52
Radiotherapy
47
Rituximab
46
Cyclosporine
46
Doxorubicin
38
Antilymphocyte Serum
37
Thiotepa
35
Granulocyte Colony-Stimulating Factor
35
Prednisone
34
Mercaptopurine
34
blinatumomab
33
pegaspargase
27
Methylprednisolone
27
Daunorubicin
26
Clofarabine
26
Asparaginase
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Interferons
×
Clear all
NCT00763763
2011-10-05
AFR07
Assistance Publique - Hôpitaux de Paris
Phase 2
Completed
55 enrolled